Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
4.250
+0.030 (0.71%)
At close: Feb 12, 2026, 4:00 PM EST
4.240
-0.010 (-0.24%)
After-hours: Feb 12, 2026, 4:10 PM EST
Actuate Therapeutics Analyst Ratings
Total Analysts
2
Consensus Rating
Strong Buy
Price Target
$20.00
Upside
+370.59%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +370.59% | Nov 19, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +370.59% | Sep 23, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +370.59% | Aug 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +370.59% | Aug 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +370.59% | Mar 17, 2025 |